Increasing daily protein by 25g lowers hip fracture odds by 14 percent in study
By
Alicia Lasek
Nov 30, 2022
Women who increase their daily protein intake by 25 grams have a 14% lower risk of hip fracture, and underweight women may derive even more benefit, food scientists report.
Depression drug eases Alzheimer’s agitation; new death in lecanemab trial raises concerns
By
Alicia Lasek
Nov 30, 2022
Two drugs in late-stage clinical trials are making news, one as a potential treatment for agitation, and the other for evidence of bleeding risk.
Vision impairment, blindness affect 66 percent of nursing home residents in study
By
Alicia Lasek
Nov 29, 2022
Vision impairment and blindness were linked to morbidity in a study across 74 facilities. But corrective lenses may play a big role in improving resident outcomes, researchers say.
New CMS guidance nudges nursing homes to offer COVID shots, timely treatments
By
Alicia Lasek
Nov 23, 2022
The agency reminds nursing facilities of the requirement to actively offer updated COVID vaccines and urges them to provide approved treatments early to keep mild symptoms from escalating.
Antimicrobial stewardship program appears to boost levofloxacin’s powers in study
By
Alicia Lasek
Nov 22, 2022
A pharmacist-led program reduced the use of fluoroquinolone antibiotics by 74% over a five-year period, and appears to have subsequently increased the ability of one of these drugs to fight common bacterial...
Older adults with atrial fibrillation remain undertreated with oral anticoagulants — despite the availability of new and better drugs, investigators say.
CMS, OIG agree on increasing scrutiny of psychotropic drug use
By
Joe Bush
Nov 18, 2022
The Centers for Medicare & Medicaid Services will be increasing its oversight of the use of psychotropic drugs to pay closer attention to certain classes, warned the lead author of a federal report identifying...
Mindfulness-based stress reduction safe, effective for anxiety disorders
Nov 10, 2022
In a randomized study, mindfulness-based stress reduction was found to be noninferior to Lexapro (escitalopram).
Brain changes after COVID ‘real’ and prevalent, researchers tell clinicians
By
Alicia Lasek
Nov 16, 2022
New evidence shows that COVID-19 can have long-term, adverse impacts on brain health — even after mild illness. Clinicians should take note, experts say.
New treatment, prevention toolkit for clinicians addresses ‘tripledemic’
By
Alicia Lasek
Nov 15, 2022
Five medical societies have created a toolkit designed to help clinicians increase the effectiveness, accessibility and awareness of oral antiviral therapeutics and COVID-19 booster vaccines.